In the evaluation on climate change conducted by the CDP, a global e...
Basic Policy for Human Rights Human Rights Due Diligence Access to R...
ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...
Human Rights Due Diligence Promotion System We recognize that we may...
We recognize our responsibility, as a pharmaceutical company involved in ...
For ONO group, to realize a sustainable society and continuous growth, it...
Corporate Governance Structure Corporate Governance Code Corporate...
We conduct environmental efficiency assessments to quantitatively measure t...
DE&I Initiatives (Promotion of diverse human resources) Other Init...
We disclose financial results and other timely disclosure information ...
We have established a policy for reducing GHG emissions based on recen...
In the Water Security survey conducted by CDP, a global environmental no...
We provide training for all employees involved in promotion activities to...
World Cancer Day is a global initiative of the UICC (Union for Interna...
Since FY2014, ONO has been a constant supporting member of a public i...
We are moving ahead with activities to achieve our medium- to long-ter...
On November 12, 2021, we concluded an agreement with Osaka Prefect...
We aim for highly transparent management, recognize the importance of ...
Our stakeholders include patients, healthcare professionals, shareholde...
In promotion activities, it is important to quickly collect safety inform...
The Ono Pharmaceutical Group's performance may be significantly affected ...
Collaboration with business partners is essential to reducing Scope 3 ...
